{
  "drug_name": "Primaquine",
  "url": "https://wikem.org/wiki/Primaquine",
  "scraped_at": "2026-01-10T08:00:34.433574",
  "sections": {
    "Administration": {
      "text": "Type:\nAntimalarial\n, anti-\nPCP\nDosage Forms:\nRoutes of Administration: oral\nCommon Trade Names:",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Antimalarial",
          "url": "https://wikem.org/wiki/Antimalarial"
        },
        {
          "text": "PCP",
          "url": "https://wikem.org/wiki/PCP"
        }
      ]
    },
    "Adult_Dosing": {
      "text": "PCP pneumonia\n, HIV+Â : 15-30mg PO daily with clindamycin\nMalaria\ntreatment: 26.3-52.6mg PO daily in combination with an additional anti-malarial agent\nMalaria\nprophylaxis: 52.6mg PO daily starting 1-2 days prior to arrival in endemic area until 7-14 days after departure",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "PCP pneumonia",
          "url": "https://wikem.org/wiki/PCP_pneumonia"
        },
        {
          "text": "Malaria",
          "url": "https://wikem.org/wiki/Malaria"
        },
        {
          "text": "Malaria",
          "url": "https://wikem.org/wiki/Malaria"
        }
      ]
    },
    "Pediatric_Dosing": {
      "text": "Malaria\ntreatment: 0.8 mg/kg PO daily (max 52.6mg daily) in combination with an additional anti-malarial agent\nMalaria\nprophylaxis: 0.8 mg/kg PO daily (max 52.6mg daily) starting 1-2 days prior to arrival in endemic area until 7-14 days after departure",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Malaria",
          "url": "https://wikem.org/wiki/Malaria"
        },
        {
          "text": "Malaria",
          "url": "https://wikem.org/wiki/Malaria"
        }
      ]
    },
    "Special_Populations": {
      "text": "Pregnancy Rating\n: D\nLactation risk\n: Infant risk cannot be ruled out\nRenal dosing:\nHepatic dosing:",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Rating",
          "url": "https://wikem.org/wiki/Drug_Ratings_in_Pregnancy"
        },
        {
          "text": "Lactation risk",
          "url": "https://wikem.org/wiki/Lactation_risk_categories"
        }
      ]
    },
    "Contraindications": {
      "text": "Allergy to class/drug\nConcomitant use with other potentially hemolytic or myeloid suppressing drugs\nAcutely ill patients with diseases prone to granulocytopenia (e.g. SLE or rheumatoid arthritis)",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Hemolytic anemia, leukopenia\nMethemoglobinemia",
          "tables": []
        },
        "Common": {
          "text": "Nausea, abdominal pain",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Serious": {
      "text": "Hemolytic anemia, leukopenia\nMethemoglobinemia",
      "subsections": {
        "Common": {
          "text": "Nausea, abdominal pain",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Common": {
      "text": "Nausea, abdominal pain",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life: 4-7 hours\nMetabolism:\nExcretion:",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Mechanism_of_Action": {
      "text": "Eliminates tissue infection, thus preventing erythrocytic forms of parasite",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "See_Also": {
      "text": "Malaria",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Malaria",
          "url": "https://wikem.org/wiki/Malaria"
        }
      ]
    }
  }
}